// Global Analysis Archive
Vietnam’s March 2026 implementation of Law 134/2025/QH15 establishes a risk-tiered, state-led AI governance regime that applies to domestic and foreign entities and diverges from ASEAN’s largely principle-based approach. The framework may strengthen sovereign control and regulatory clarity, but gaps on environmental resource use and worker protections could create longer-term economic and social pressures.
At India’s AI Impact Summit in New Delhi, leaders promoted wider access to AI alongside stronger safety oversight, with the UN proposing a US$3 billion Global Fund on AI. Major firms announced infrastructure and partnership moves that could expand India’s compute capacity, while sustainability and child-protection concerns emerged as key constraints on AI scale-up.
A Hogan Lovells panel at the 2026 J.P. Morgan Healthcare Conference highlights that international expansion in life sciences is increasingly shaped by AI regulation, trade controls, and supply-chain security. The discussion points to faster PRC approval pathways alongside tighter data/genetic governance, and rising scrutiny of tariffs and country-of-origin representations in the U.S. and EU.
Vietnam’s March 2026 implementation of Law 134/2025/QH15 establishes a risk-tiered, state-led AI governance regime that applies to domestic and foreign entities and diverges from ASEAN’s largely principle-based approach. The framework may strengthen sovereign control and regulatory clarity, but gaps on environmental resource use and worker protections could create longer-term economic and social pressures.
At India’s AI Impact Summit in New Delhi, leaders promoted wider access to AI alongside stronger safety oversight, with the UN proposing a US$3 billion Global Fund on AI. Major firms announced infrastructure and partnership moves that could expand India’s compute capacity, while sustainability and child-protection concerns emerged as key constraints on AI scale-up.
A Hogan Lovells panel at the 2026 J.P. Morgan Healthcare Conference highlights that international expansion in life sciences is increasingly shaped by AI regulation, trade controls, and supply-chain security. The discussion points to faster PRC approval pathways alongside tighter data/genetic governance, and rising scrutiny of tariffs and country-of-origin representations in the U.S. and EU.
| ID | Title | Category | Date | Views | |
|---|---|---|---|---|---|
| RPT-5500 | Vietnam’s AI Law Signals a Southeast Asia Shift Toward Binding Digital Sovereignty | Vietnam | 2026-07-28 | 0 | ACCESS » |
| RPT-1354 | India’s AI Summit Signals Global South Access Push as UN and EU Press for Stronger Guardrails | India | 2026-02-19 | 0 | ACCESS » |
| RPT-226 | JPM 2026 Briefing: Life Sciences Expansion Meets AI, Trade, and China Data Governance | Life Sciences | 2026-01-27 | 1 | ACCESS » |